iCAD And Google Health Expand Integration of Google's AI Technology With iCAD's ProFound Breast Health Suite For 2D Mammography For Use As Independent Reader
Portfolio Pulse from Happy Mohamed
iCAD, Inc. (NASDAQ:ICAD) has expanded its agreement with Google Health to integrate Google's AI technology with iCAD's ProFound Breast Health Suite for 2D Mammography. The technology will be used as an independent reader for breast cancer screening worldwide upon regulatory approval. The integration aims to address the global shortage of radiologists and improve efficiency in mammography reading. In a study, Google's AI system outperformed human readers in mammography reading, reducing the workload of the second reader by 88%.
August 14, 2023 | 12:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Google's AI technology will be integrated into iCAD's ProFound Breast Health Suite for 2D Mammography. This partnership could enhance Google's presence in the healthcare sector and potentially increase the use of its AI technology.
The partnership with iCAD could increase the use of Google's AI technology in the healthcare sector, potentially leading to more partnerships and increased revenue from its AI technology.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
iCAD's expanded agreement with Google Health to integrate Google's AI technology could improve the efficiency and accuracy of its ProFound Breast Health Suite for 2D Mammography. This could potentially increase the demand for iCAD's product.
The integration of Google's AI technology could enhance the capabilities of iCAD's product, making it more attractive to healthcare organizations. This could potentially lead to increased sales and revenue for iCAD.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100